Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.

Monzani D, Barillari MR, Alicandri Ciufelli M, Aggazzotti Cavazza E, Neri V, Presutti L, Genovese E.

Acta Otorhinolaryngol Ital. 2012 Dec;32(6):393-403.

3.

Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.

Bodmer D, Morong S, Stewart C, Alexander A, Chen JM, Nedzelski JM.

Otol Neurotol. 2007 Dec;28(8):1140-4.

PMID:
18084826
4.
5.
6.

Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial.

Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K, Zingler VC, Mansmann U, Brandt T.

Acta Otolaryngol. 2008 May;128(5):520-4. doi: 10.1080/00016480701724912.

PMID:
18421605
7.

[Trimetazidine versus betahistine in Ménière's disease. A double blind method].

Martini A, De Domenico F.

Ann Otolaryngol Chir Cervicofac. 1990;107 Suppl 1:20-7. French.

PMID:
2240995
8.

[Treatment of Menière's disease with betahistine (author's transl)].

Stupp H, Kahl S.

HNO. 1976 Sep;24(9):320-5. German.

PMID:
965272
9.

Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.

Rajan GP, Din S, Atlas MD.

J Laryngol Otol. 2005 May;119(5):391-5.

PMID:
15949105
10.

High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series.

Lezius F, Adrion C, Mansmann U, Jahn K, Strupp M.

Eur Arch Otorhinolaryngol. 2011 Aug;268(8):1237-40. doi: 10.1007/s00405-011-1647-2. Epub 2011 May 29.

PMID:
21626121
11.

Betahistine for Menière's disease or syndrome.

James AL, Burton MJ.

Cochrane Database Syst Rev. 2001;(1):CD001873. Review.

PMID:
11279734
12.

Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.

Shea PF, Richey PA, Wan JY, Stevens SR.

Laryngoscope. 2012 Jan;122(1):204-11. doi: 10.1002/lary.22362.

PMID:
22183636
13.

Alternobaric oxygen therapy in long-term treatment of Ménière's disease.

Fattori B, De Iaco G, Nacci A, Casani A, Ursino F.

Undersea Hyperb Med. 2002 Winter;29(4):260-70.

PMID:
12797667
14.

[Trimetazidine versus betahistine in vestibular vertigo. A double blind study].

Kluyskens P, Lambert P, D'Hooge D.

Ann Otolaryngol Chir Cervicofac. 1990;107 Suppl 1:11-9. French.

PMID:
2240994
15.

Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.

Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.

Otolaryngol Head Neck Surg. 2005 Aug;133(2):285-94.

PMID:
16087029
16.

Use of nimodipine in the medical treatment of Menière's disease: clinical experience.

Lassen LF, Hirsch BE, Kamerer DB.

Am J Otol. 1996 Jul;17(4):577-80.

PMID:
8841703
17.
18.

Betahistine in Ménière's disease.

Wilmot TJ, Menon GN.

J Laryngol Otol. 1976 Sep;90(9):833-40.

PMID:
787460
19.

Betahistine hydrochloride in Méniére's disease.

Frew IJ, Menon GN.

Postgrad Med J. 1976 Aug;52(610):501-3.

20.

Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.

Mira E, Guidetti G, Ghilardi L, Fattori B, Malannino N, Maiolino L, Mora R, Ottoboni S, Pagnini P, Leprini M, Pallestrini E, Passali D, Nuti D, Russolo M, Tirelli G, Simoncelli C, Brizi S, Vicini C, Frasconi P.

Eur Arch Otorhinolaryngol. 2003 Feb;260(2):73-7. Epub 2002 Sep 11.

PMID:
12582782
Items per page

Supplemental Content

Write to the Help Desk